Latest Governance News

QEM Limited confirms a $1.442 million capital raising via placement, addressing ASX queries on disclosure timing and compliance. The company clarifies board approvals and trading halt details, reinforcing its adherence to continuous disclosure obligations.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.

Santana Minerals has completed a substantial A$113 million unconditional placement, with plans underway to seek shareholder approval for an additional $17 million capital raise. The move signals a significant boost to the company’s financial firepower as it advances its mining ambitions.

Scentre Group reported robust 2025 results with a 4.9% rise in Funds From Operations and record customer visitation, while progressing key sustainability and growth initiatives.

Kelsian Group Limited has reported a robust first half for FY26 with double-digit revenue growth and upgraded EBITDA guidance, alongside a strategic $161 million sale of its Tourism Portfolio.

Olympio Metals has secured binding agreements to acquire two historically high-grade silver and antimony projects in the US, backed by a $3 million capital raise including vendor participation.

Greenwing Resources has significantly enhanced the economics of its Que River Project following a sharp rise in key metal prices, nearly doubling projected cash flows and advancing a two-stage development plan.

Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.

Bass Oil has received a $3.5 million grant from the South Australian Government to fund pipeline construction for its Kiwi liquids rich gas project in the Cooper Basin, marking a key step towards production by 2028.

Red Mountain Mining is making significant strides in its US critical minerals portfolio, reporting strong antimony assay results and gearing up for extensive exploration programs. The company’s projects align closely with US and Australian government initiatives to secure domestic critical metal supplies.

OncoSil Medical has reported record dose sales and cash receipts in the first half of FY26, supported by encouraging clinical trial results and expanded European market penetration.

Viva Energy Group Limited reported a significant net loss for 2025, driven by retail asset impairments, yet underlying profits and strategic investments signal resilience and a clear path forward.